N-(1-(3-chlorophenyl)-2-hydroxyethyl)-3-(tetrahydro-2H-pyran-4-yl)-1H-indazole-5-carboxamide

ID: ALA3798700

Chembl Id: CHEMBL3798700

PubChem CID: 127047026

Max Phase: Preclinical

Molecular Formula: C21H22ClN3O3

Molecular Weight: 399.88

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(NC(CO)c1cccc(Cl)c1)c1ccc2[nH]nc(C3CCOCC3)c2c1

Standard InChI:  InChI=1S/C21H22ClN3O3/c22-16-3-1-2-14(10-16)19(12-26)23-21(27)15-4-5-18-17(11-15)20(25-24-18)13-6-8-28-9-7-13/h1-5,10-11,13,19,26H,6-9,12H2,(H,23,27)(H,24,25)

Standard InChI Key:  QCFBVHCFUXZZKC-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3798700

    ---

Associated Targets(Human)

MAPK3 Tchem MAP kinase ERK1 (4725 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK1 Tchem MAP kinase ERK2 (25055 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.88Molecular Weight (Monoisotopic): 399.1350AlogP: 3.57#Rotatable Bonds: 5
Polar Surface Area: 87.24Molecular Species: NEUTRALHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 13.70CX Basic pKa: 2.10CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.61Np Likeness Score: -1.16

References

1. Li L, Liu F, Jin N, Tang S, Chen Z, Yang X, Ding J, Geng M, Jiang L, Huang M, Cao J..  (2016)  Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2).,  26  (11): [PMID:27106711] [10.1016/j.bmcl.2016.04.029]

Source